Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Comparative Observation of Immediate and Late Placement of Dental Implants With Immediate Loading: A 14-Year Follow-Up Case Report.

Ohyama H, Hamilton A, Forman MS, Weber HP.

J Oral Implantol. 2019 Aug;45(4):313-318. doi: 10.1563/aaid-joi-D-18-00290. Epub 2019 Apr 22. No abstract available.

PMID:
31008685
2.

Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Ticehurst JR, Pisanic N, Forman MS, Ordak C, Heaney CD, Ong E, Linnen JM, Ness PM, Guo N, Shan H, Nelson KE.

Transfusion. 2019 Mar;59(3):1024-1034. doi: 10.1111/trf.15140. Epub 2019 Jan 31.

PMID:
30702157
3.

Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study.

Chris Min K, Dockendorf MF, Palcza J, Tseng J, Ma L, Stone JA, Kleijn HJ, Hodsman P, Masuo K, Tanen M, Troyer MD, van Vugt M, Forman MS.

Clin Pharmacol Ther. 2019 May;105(5):1234-1243. doi: 10.1002/cpt.1258. Epub 2019 Jan 18.

PMID:
30347431
4.

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.

Greer AE, Ou SS, Wilson E, Piwowar-Manning E, Forman MS, McCauley M, Gamble T, Ruangyuttikarn C, Hosseinipour MC, Kumarasamy N, Nyirenda M, Grinsztejn B, Pilotto JH, Kosashunhanan N, Gonçalves de Melo M, Makhema J, Akelo V, Panchia R, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH, Thio CL, Valsamakis A.

J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):388-393. doi: 10.1097/QAI.0000000000001511.

5.

Cytomegalovirus Kinetics Following Primary Infection in Healthy Women.

Forman MS, Vaidya D, Bolorunduro O, Diener-West M, Pass RF, Arav-Boger R.

J Infect Dis. 2017 May 15;215(10):1523-1526. doi: 10.1093/infdis/jix188.

6.

Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization.

Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R.

Clin Cancer Res. 2017 Jun 15;23(12):3150-3157. doi: 10.1158/1078-0432.CCR-16-1490. Epub 2016 Dec 29.

7.

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients.

Kennedy ME, Stamford AW, Chen X, Cox K, Cumming JN, Dockendorf MF, Egan M, Ereshefsky L, Hodgson RA, Hyde LA, Jhee S, Kleijn HJ, Kuvelkar R, Li W, Mattson BA, Mei H, Palcza J, Scott JD, Tanen M, Troyer MD, Tseng JL, Stone JA, Parker EM, Forman MS.

Sci Transl Med. 2016 Nov 2;8(363):363ra150.

PMID:
27807285
8.

Variability between credit units dedicated to dental and clinical sciences in dental schools across the USA.

Nalliah RP, Forman MS, Chavis SE, Timothé P.

J Investig Clin Dent. 2017 Aug;8(3). doi: 10.1111/jicd.12229. Epub 2016 Aug 4.

PMID:
27492786
9.

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.

Gotter AL, Forman MS, Harrell CM, Stevens J, Svetnik V, Yee KL, Li X, Roecker AJ, Fox SV, Tannenbaum PL, Garson SL, Lepeleire ID, Calder N, Rosen L, Struyk A, Coleman PJ, Herring WJ, Renger JJ, Winrow CJ.

Sci Rep. 2016 Jun 3;6:27147. doi: 10.1038/srep27147.

10.

The Accuracy of Clinical Diagnosis of Oral Lesions and Patient-Specific Risk Factors that Affect Diagnosis.

Forman MS, Chuang SK, August M.

J Oral Maxillofac Surg. 2015 Oct;73(10):1932-7. doi: 10.1016/j.joms.2015.04.026. Epub 2015 May 7.

PMID:
25981860
11.

Comparison of BKV quantification using a single automated nucleic acid extraction platform and 3 real-time PCR assays.

Greer AE, Forman MS, Valsamakis A.

Diagn Microbiol Infect Dis. 2015 Aug;82(4):297-302. doi: 10.1016/j.diagmicrobio.2015.04.006. Epub 2015 Apr 25.

PMID:
25971156
12.

Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort.

Forman MS, Advani S, Newman C, Gaydos CA, Milstone AM, Valsamakis A.

J Clin Virol. 2012 Oct;55(2):168-72. doi: 10.1016/j.jcv.2012.06.019. Epub 2012 Jul 24.

13.

Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.

Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC.

Toxins (Basel). 2010 Dec;2(12):2824-36. doi: 10.3390/toxins2122824. Epub 2010 Dec 14.

14.

Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.

Murthy S, Hayward GS, Wheelan S, Forman MS, Ahn JH, Pass RF, Arav-Boger R.

PLoS One. 2011 Jan 10;6(1):e15949. doi: 10.1371/journal.pone.0015949.

15.

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.

Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, Tang W, Winton MJ, Neumann M, Trojanowski JQ, Lee VM, Forman MS, Taylor JP.

J Neurosci. 2010 Jun 2;30(22):7729-39. doi: 10.1523/JNEUROSCI.5894-09.2010.

16.

Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.

Jabs DA, Martin BK, Forman MS; Cytomegalovirus Retinitis and Viral Resistance Research Group.

Ophthalmology. 2010 Jan;117(1):128-132.e2. doi: 10.1016/j.ophtha.2009.06.016. Epub 2009 Oct 8.

17.

VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Gitcho MA, Strider J, Carter D, Taylor-Reinwald L, Forman MS, Goate AM, Cairns NJ.

J Biol Chem. 2009 May 1;284(18):12384-98. doi: 10.1074/jbc.M900992200. Epub 2009 Feb 23.

18.

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies.

Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, Kretzschmar HA, Trojanowski JQ, Lee VM.

Acta Neuropathol. 2009 Feb;117(2):137-49. doi: 10.1007/s00401-008-0477-9. Epub 2009 Jan 6.

19.

Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.

Sarrazin C, Dragan A, Gärtner BC, Forman MS, Traver S, Zeuzem S, Valsamakis A.

J Clin Virol. 2008 Oct;43(2):162-8. doi: 10.1016/j.jcv.2008.06.013. Epub 2008 Aug 8.

PMID:
18692434
20.

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M.

J Neuropathol Exp Neurol. 2008 Jun;67(6):555-64. doi: 10.1097/NEN.0b013e31817713b5.

21.

Longitudinal decline in autopsy-defined frontotemporal lobar degeneration.

Grossman M, Xie SX, Libon DJ, Wang X, Massimo L, Moore P, Vesely L, Berkowitz R, Chatterjee A, Coslett HB, Hurtig HI, Forman MS, Lee VM, Trojanowski JQ.

Neurology. 2008 May 27;70(22):2036-45. doi: 10.1212/01.wnl.0000303816.25065.bc. Epub 2008 Apr 16.

22.
23.

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia.

Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GD.

Am J Med Genet A. 2008 Mar 15;146A(6):745-57. doi: 10.1002/ajmg.a.31862.

24.

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.

Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, Allison SC, Halabi C, Kramer JH, Johnson JK, Weiner MW, Forman MS, Trojanowski JQ, Dearmond SJ, Miller BL, Rosen HJ.

Am J Alzheimers Dis Other Demen. 2007 Dec-2008 Jan;22(6):474-88. doi: 10.1177/1533317507308779.

25.

Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.

Grossman M, Libon DJ, Forman MS, Massimo L, Wood E, Moore P, Anderson C, Farmer J, Chatterjee A, Clark CM, Coslett HB, Hurtig HI, Lee VM, Trojanowski JQ.

Arch Neurol. 2007 Nov;64(11):1601-9.

PMID:
17998442
26.

Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.

Hayden RT, Hokanson KM, Pounds SB, Bankowski MJ, Belzer SW, Carr J, Diorio D, Forman MS, Joshi Y, Hillyard D, Hodinka RL, Nikiforova MN, Romain CA, Stevenson J, Valsamakis A, Balfour HH Jr; U.S. EBV Working Group.

J Clin Microbiol. 2008 Jan;46(1):157-63. Epub 2007 Nov 7.

27.

TDP-43: a novel neurodegenerative proteinopathy.

Forman MS, Trojanowski JQ, Lee VM.

Curr Opin Neurobiol. 2007 Oct;17(5):548-55. Epub 2007 Oct 23.

28.

TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions.

Grossman M, Wood EM, Moore P, Neumann M, Kwong L, Forman MS, Clark CM, McCluskey LF, Miller BL, Lee VM, Trojanowski JQ.

Arch Neurol. 2007 Oct;64(10):1449-54.

PMID:
17923628
29.

Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.

Van Deerlin VM, Wood EM, Moore P, Yuan W, Forman MS, Clark CM, Neumann M, Kwong LK, Trojanowski JQ, Lee VM, Grossman M.

Arch Neurol. 2007 Aug;64(8):1148-53.

PMID:
17698705
30.

Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration.

Xie SX, Forman MS, Farmer J, Moore P, Wang Y, Wang X, Clark CM, Coslett HB, Chatterjee A, Arnold SE, Rosen H, Karlawish JH, Van Deerlin VM, Lee VM, Trojanowski JQ, Grossman M.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):126-9. Epub 2007 Jul 5.

PMID:
17615171
31.

TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.

Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR.

Am J Pathol. 2007 Jul;171(1):227-40.

32.

Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM, Trojanowski JQ.

Ann Neurol. 2007 May;61(5):427-34.

PMID:
17469116
33.

Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.

Guinto JB, Ritson GP, Taylor JP, Forman MS.

Acta Neuropathol. 2007 Jul;114(1):55-61. Epub 2007 Apr 25. Review.

PMID:
17457594
34.

Cognitive and motor assessment in autopsy-proven corticobasal degeneration.

Murray R, Neumann M, Forman MS, Farmer J, Massimo L, Rice A, Miller BL, Johnson JK, Clark CM, Hurtig HI, Gorno-Tempini ML, Lee VM, Trojanowski JQ, Grossman M.

Neurology. 2007 Apr 17;68(16):1274-83.

PMID:
17438218
35.

Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.

Martin BK, Ricks MO, Forman MS, Jabs DA; Cytomegalovirus Retinitis and Viral Resistance Study Group.

Clin Infect Dis. 2007 Apr 1;44(7):1001-8. Epub 2007 Feb 20.

PMID:
17342657
36.

Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.

Forman MS, Mufson EJ, Leurgans S, Pratico D, Joyce S, Leight S, Lee VM, Trojanowski JQ.

Neurology. 2007 Mar 6;68(10):757-63.

PMID:
17339583
37.

TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS.

J Neuropathol Exp Neurol. 2007 Feb;66(2):152-7.

PMID:
17279000
38.

From progressive nonfluent aphasia to corticobasal syndrome: a case report of corticobasal degeneration.

Sánchez-Valle R, Forman MS, Miller BL, Gorno-Tempini ML.

Neurocase. 2006 Dec;12(6):355-9.

PMID:
17182400
39.

The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J.

Neurobiol Dis. 2007 Mar;25(3):561-70. Epub 2006 Dec 15.

PMID:
17174556
40.

Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.

Van Deerlin VM, Forman MS, Farmer JM, Grossman M, Joyce S, Crowe A, Trojanowski JQ, Lee VM, Chatterjee A.

Acta Neuropathol. 2007 Apr;113(4):471-9. Epub 2006 Oct 28.

PMID:
17072625
41.

Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.

Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestronk A, Smith TW, Tu PH, Watts GD, Markesbery WR, Smith CD, Kimonis VE.

J Neuropathol Exp Neurol. 2006 Jun;65(6):571-81.

PMID:
16783167
42.

Frontotemporal dementia: clinicopathological correlations.

Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M.

Ann Neurol. 2006 Jun;59(6):952-62.

43.

Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.

Jabs DA, Martin BK, Ricks MO, Forman MS; Cytomegalovirus Retinitis and Viral Resistance Study Group.

J Infect Dis. 2006 Jun 15;193(12):1728-37. Epub 2006 May 10.

PMID:
16703517
44.

Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum.

Clark CM, Forman MS.

Arch Neurol. 2006 Apr;63(4):489-90. No abstract available.

PMID:
16606759
45.

Impaired glutamate transport in a mouse model of tau pathology in astrocytes.

Dabir DV, Robinson MB, Swanson E, Zhang B, Trojanowski JQ, Lee VM, Forman MS.

J Neurosci. 2006 Jan 11;26(2):644-54.

46.

Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.

Higuchi M, Zhang B, Forman MS, Yoshiyama Y, Trojanowski JQ, Lee VM.

J Neurosci. 2005 Oct 12;25(41):9434-43.

47.

Genotypically defined lissencephalies show distinct pathologies.

Forman MS, Squier W, Dobyns WB, Golden JA.

J Neuropathol Exp Neurol. 2005 Oct;64(10):847-57.

PMID:
16215456
48.

Frontotemporal dementia progresses to death faster than Alzheimer disease.

Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, Forman MS, Miller CA, Trojanowski JQ, Kramer JH, Miller BL.

Neurology. 2005 Sep 13;65(5):719-25.

PMID:
16157905
49.

Nosology of Parkinson's disease: looking for the way out of a quagmire.

Forman MS, Lee VM, Trojanowski JQ.

Neuron. 2005 Aug 18;47(4):479-82. Review.

50.

Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis.

Jabs DA, Martin BK, Forman MS, Ricks MO; Cytomegalovirus Retinitis and Viral Resistance Research Group.

J Infect Dis. 2005 Aug 15;192(4):640-9. Epub 2005 Jul 11. Erratum in: J Infect Dis. 2005 Oct 1;192(7):1310.

PMID:
16028133

Supplemental Content

Loading ...
Support Center